Electroencephalography characteristics related to risk of sudden unexpected death in epilepsy in patients with Dravet syndrome
- PMID: 37745659
- PMCID: PMC10512954
- DOI: 10.3389/fneur.2023.1222721
Electroencephalography characteristics related to risk of sudden unexpected death in epilepsy in patients with Dravet syndrome
Abstract
Objective: To investigate the quantitative electroencephalography (EEG) features associated with a high risk of sudden unexpected death in epilepsy (SUDEP) in patients with Dravet syndrome (DS).
Methods: Patients with DS and healthy controls (HCs) who underwent EEG were included in the study. EEG signals were recorded using a 21 channel digital EEG system, and pre-processed data were analyzed to identify quantitative EEG features associated with a high SUDEP risk. To assess the risk of SUDEP, SUDEP-7 scores were used.
Results: A total of 64 patients with DS [38 males and 26 females, aged: 128.51 ± 75.50 months (range: 23-380 months)], and 13 HCs [7 males and 6 females, aged: 95.46 ± 86.48 months (range: 13-263 months)] were included. For the absolute band power, the theta power was significantly higher in the high-SUDEP group than in the low-SUDEP group in the central brain region. For the relative band power, the theta power was also significantly higher in the high-SUDEP group than in the low-SUDEP group in the central and occipital brain regions. The alpha power was significantly lower in the high-SUDEP group than in the low-SUDEP group in the central and parietal brain regions.
Conclusion: Patients with high SUDEP-7 scores have different EEG features from those with low SUDEP-7 scores, suggesting that EEG may be used as a biomarker of SUDEP in DS.
Significance: Early intervention in patients with DS at a high risk of SUDEP can reduce mortality and morbidity. Patients with high theta band powers warrant high-level supervision.
Keywords: Dravet syndrome (DS); electroencephalography (EEG); epilepsy; mortality; sudden unexpected death in epilepsy (SUDEP).
Copyright © 2023 Kim, Shin, Kim and Kim.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Life-span characterization of epilepsy and comorbidities in Dravet syndrome mice carrying a targeted deletion of exon 1 of the Scn1a gene.Exp Neurol. 2022 Aug;354:114090. doi: 10.1016/j.expneurol.2022.114090. Epub 2022 Apr 26. Exp Neurol. 2022. PMID: 35487274
-
Impact of fenfluramine on the expected SUDEP mortality rates in patients with Dravet syndrome.Seizure. 2021 Dec;93:154-159. doi: 10.1016/j.seizure.2021.10.024. Epub 2021 Nov 2. Seizure. 2021. PMID: 34768178
-
Peri-ictal Prone Position Is Associated With Independent Risk Factors For Sudden Unexpected Death In Epilepsy: A Controlled Video-EEG Monitoring Unit Study.Clin EEG Neurosci. 2018 May;49(3):197-205. doi: 10.1177/1550059417733385. Epub 2017 Sep 28. Clin EEG Neurosci. 2018. PMID: 28958162
-
Spotlight on mechanism of sudden unexpected death in epilepsy in Dravet syndrome.Transl Psychiatry. 2025 Mar 17;15(1):84. doi: 10.1038/s41398-025-03304-8. Transl Psychiatry. 2025. PMID: 40097380 Free PMC article. Review.
-
Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP).Cochrane Database Syst Rev. 2020 Apr 2;4(4):CD011792. doi: 10.1002/14651858.CD011792.pub3. Cochrane Database Syst Rev. 2020. PMID: 32239759 Free PMC article.
Cited by
-
Sudden unexpected death in epilepsy: respiratory vs. cardiac contributions.Cardiovasc Res. 2025 Apr 8;120(18):2385-2394. doi: 10.1093/cvr/cvae170. Cardiovasc Res. 2025. PMID: 39110639 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources